295 related articles for article (PubMed ID: 26159539)
1. The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.
Strand TE; Rostad H; Strøm EH; Hasleton P
Diagn Pathol; 2015 Jul; 10():94. PubMed ID: 26159539
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
[TBL] [Abstract][Full Text] [Related]
3. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
4. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
[TBL] [Abstract][Full Text] [Related]
5. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
Sakurai H; Dobashi Y; Mizutani E; Matsubara H; Suzuki S; Takano K; Shindo S; Matsumoto M
Ann Thorac Surg; 2004 Nov; 78(5):1728-33. PubMed ID: 15511463
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
7. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma.
Sasada S; Miyata Y; Mimae T; Mimura T; Okada M
Ann Thorac Surg; 2015 Dec; 100(6):2079-86. PubMed ID: 26298165
[TBL] [Abstract][Full Text] [Related]
8. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
[TBL] [Abstract][Full Text] [Related]
9. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
[TBL] [Abstract][Full Text] [Related]
10. The importance of the lepidic component as a prognostic factor in stage I pulmonary adenocarcinoma.
Moon Y; Sung SW; Lee KY; Kim YK; Park JK
World J Surg Oncol; 2016 Feb; 14(1):37. PubMed ID: 26879575
[TBL] [Abstract][Full Text] [Related]
11. Impact of smoking on outcome of resected lung adenocarcinoma.
Tomita M; Ayabe T; Chosa E; Nakamura K
Gen Thorac Cardiovasc Surg; 2015 Nov; 63(11):608-12. PubMed ID: 26243355
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the new IASLC/ATS/ERS proposed classification of adenocarcinoma based on lepidic pattern in patients with pathological stage IA pulmonary adenocarcinoma.
Nakagiri T; Sawabata N; Morii E; Inoue M; Shintani Y; Funaki S; Okumura M
Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):671-7. PubMed ID: 24890089
[TBL] [Abstract][Full Text] [Related]
13. Surgery for bronchioloalveolar carcinoma and "very early" adenocarcinoma: an evolving standard of care?
Rusch VW; Tsuchiya R; Tsuboi M; Pass HI; Grunenwald D; Goldstraw P
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S27-31. PubMed ID: 17409998
[TBL] [Abstract][Full Text] [Related]
14. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice.
Casali C; Rossi G; Marchioni A; Sartori G; Maselli F; Longo L; Tallarico E; Morandi U
J Thorac Oncol; 2010 Jun; 5(6):830-6. PubMed ID: 20521350
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma.
Carretta A; Canneto B; Calori G; Ceresoli GL; Campagnoli E; Arrigoni G; Vagani A; Zannini P
Eur J Cardiothorac Surg; 2001 Aug; 20(2):367-71. PubMed ID: 11463559
[TBL] [Abstract][Full Text] [Related]
16. What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?
Aherne EA; Plodkowski AJ; Montecalvo J; Hayan S; Zheng J; Capanu M; Adusumilli PS; Travis WD; Ginsberg MS
Lung Cancer; 2018 Apr; 118():83-89. PubMed ID: 29572008
[TBL] [Abstract][Full Text] [Related]
17. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
18. Well-differentiated adenocarcinoma-bronchioloalveolar carcinoma-in situ adenocarcinoma: a conundrum.
Weissferdt A; Kalhor N; Moran CA
Adv Anat Pathol; 2013 Sep; 20(5):347-51. PubMed ID: 23939151
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Adenocarcinomas of Low Malignant Potential: Proposed Criteria to Expand the Spectrum Beyond Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
Yambayev I; Sullivan TB; Suzuki K; Zhao Q; Higgins SE; Yilmaz OH; Litle VR; Moreira P; Servais EL; Stock CT; Quadri SM; Williamson C; Rieger-Christ KM; Burks EJ
Am J Surg Pathol; 2021 Apr; 45(4):567-576. PubMed ID: 33177339
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Mano M; Kido S; Kuriyama K
Ann Thorac Surg; 1999 Dec; 68(6):2069-73. PubMed ID: 10616979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
